These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 25352200

  • 1. [Serious bleeding as a consequence of accumulation of dabigatran caused by renal failure].
    Skjødt-Jensen AM, Hvas AM.
    Ugeskr Laeger; 2014 Jun 09; 176(24):. PubMed ID: 25352200
    [Abstract] [Full Text] [Related]

  • 2. Idarucizumab for dabigatran overdose.
    Peetermans M, Pollack C, Reilly P, Liesenborghs L, Jacquemin M, Levy JH, Weitz JI, Verhamme P.
    Clin Toxicol (Phila); 2016 Sep 09; 54(8):644-6. PubMed ID: 27224445
    [Abstract] [Full Text] [Related]

  • 3. Hemopericardium under dabigatran for stroke prevention in atrial fibrillation.
    Stöllberger C, Heger M, Finsterer J.
    Blood Coagul Fibrinolysis; 2017 Mar 09; 28(2):185-188. PubMed ID: 26945264
    [Abstract] [Full Text] [Related]

  • 4. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L, Chen C, White J.
    Consult Pharm; 2014 Mar 09; 29(3):169-78. PubMed ID: 24589766
    [Abstract] [Full Text] [Related]

  • 5. Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review.
    Milling TJ, Fromm C, Ganetsky M, Pallin DJ, Cong J, Singer AJ.
    Ann Emerg Med; 2017 May 09; 69(5):531-540. PubMed ID: 28196608
    [Abstract] [Full Text] [Related]

  • 6. Treatment of dabigatran-associated bleeding: case report and review of the literature.
    Harinstein LM, Morgan JW, Russo N.
    J Pharm Pract; 2013 Jun 09; 26(3):264-9. PubMed ID: 23160864
    [Abstract] [Full Text] [Related]

  • 7. Observational study of dabigatran etexilate 150mg in patients with moderate renal impairment undergoing elective total hip or knee replacement.
    Samama CM, Rosencher N, Kleine E, Feuring M, Brueckmann M, Clemens A, Gullberg J, Frostick SP.
    Thromb Res; 2016 Jul 09; 143():103-10. PubMed ID: 27208980
    [Abstract] [Full Text] [Related]

  • 8. Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients.
    Molteni M, Bo M, Di Minno G, Di Pasquale G, Genovesi S, Toni D, Verdecchia P.
    Intern Emerg Med; 2017 Jun 09; 12(4):425-435. PubMed ID: 28439778
    [Abstract] [Full Text] [Related]

  • 9. Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.
    Sié P.
    Drug Des Devel Ther; 2016 Jun 09; 10():1683-9. PubMed ID: 27274201
    [Abstract] [Full Text] [Related]

  • 10. Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia.
    Beshir SA, Chee KH, Lo YL.
    Int J Clin Pharm; 2016 Oct 09; 38(5):1182-90. PubMed ID: 27450507
    [Abstract] [Full Text] [Related]

  • 11. Bleeding risk in patients treated with dabigatran or vitamin K antagonist for atrial fibrillation: A meta analysis of adjusted analysis in routine practice settings.
    Darwiche W, Bejan-Angoulvant T, Dievart F, Babuty D, Angoulvant D, Fauchier L.
    Int J Cardiol; 2016 Mar 01; 206():89-92. PubMed ID: 26785030
    [No Abstract] [Full Text] [Related]

  • 12. [Successful treatment of severe dabigatran intoxication with idarucizumab in a patient with acute kidney injury].
    Poulsen CG, Bestle M, Boesby L.
    Ugeskr Laeger; 2017 Feb 13; 179(7):. PubMed ID: 28397672
    [Abstract] [Full Text] [Related]

  • 13. Real Data on Effectiveness, Tolerability and Safety of New Oral Anticoagulant Agents: Focus on Dabigatran.
    Stabile E, Izzo R, Rozza F, Losi MA, Coscioni E, Trimarco B.
    High Blood Press Cardiovasc Prev; 2016 Jun 13; 23(2):115-22. PubMed ID: 27207360
    [Abstract] [Full Text] [Related]

  • 14. [Anticoagulant therapy with dabigatran in elderly patients ≥80 years of age with atrial fibrillation].
    Kono T, Ogimoto A, Aono J, Okura T, Shigematsu Y, Higaki J.
    Nihon Ronen Igakkai Zasshi; 2014 Jun 13; 51(4):350-5. PubMed ID: 25327369
    [Abstract] [Full Text] [Related]

  • 15. The assessment of anticoagulant activity to predict bleeding outcome in atrial fibrillation patients receiving dabigatran etexilate.
    Chang YT, Hu YF, Liao JN, Chern CM, Lin YJ, Chang SL, Wu CH, Sung SH, Wang KL, Lu TM, Chao TF, Lo LW, Hsu LC, Chung CP, Chang PM, Hsu WH, Chiou CW, Chen SA.
    Blood Coagul Fibrinolysis; 2016 Jun 13; 27(4):389-95. PubMed ID: 26991859
    [Abstract] [Full Text] [Related]

  • 16. [Hemodialysis to remove anticoagulant dabigatran during emergencies].
    Carrizo A, Campbell S.
    Medicina (B Aires); 2014 Jun 13; 74(2):121-3. PubMed ID: 24736256
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectivity of hemodialysis in acute gastrointestinal bleeding associated with dabigatran overdose.
    Kilit C, Erarslan S, Pasali Kilit T.
    Acta Gastroenterol Belg; 2017 Jun 13; 80(2):322. PubMed ID: 29560702
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.